Introduction
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare but severe autoimmune disease characterized by inflammation in small-to-medium blood vessels. While the condition is well-documented in adults, pediatric AAV remains less understood, particularly concerning long-term renal survival. Most existing data originate from Western cohorts where Granulomatosis with polyangiitis (GPA) is more common. In contrast, East Asian populations exhibit a higher prevalence of Microscopic polyangiitis (MPA). This study aims to identify clinical and histological markers that predict progression to end-stage renal disease (ESRD) in a Chinese pediatric population.
Methods
A retrospective cohort analysis was conducted on 48 pediatric patients (under age 18) treated at Tongji Hospital in Wuhan, China, between 2002 and 2021. Kidney biopsies, available for 33 patients, were categorized using Berden’s classification into four subtypes: focal, crescentic, sclerotic, and mixed. The standard treatment protocol involved induction therapy with glucocorticoids and monthly intravenous cyclophosphamide (CYC) for six months. Renal function was assessed via estimated glomerular filtration rate (eGFR), and remission was evaluated at the six-month mark. Kaplan–Meier curves and Cox regression models were employed to identify independent risk factors for ESRD.
Key Insights: Histology and Treatment Response
Histology as a Roadmap
The pathological subtype of the kidney at diagnosis serves as a critical indicator of long-term health. According to Berden’s classification, the "sclerotic" subtype, which is characterized by advanced scarring in the glomeruli, showed the poorest prognosis. Conversely, the "focal" subtype, representing minimal glomerular involvement, was associated with the best renal survival rates.
The Critical Six Months
The study underscores the importance of the initial response to induction therapy. Patients who failed to achieve at least partial remission within the first six months of treatment faced a significantly higher risk of progressing to ESRD. This "induction response" is a powerful predictor of long-term outcomes, highlighting a critical window for clinical intervention.
Results and Predictive Factors
The analysis revealed a high rate of progression to ESRD, with 50% of patients reaching this stage within a mean time of 13.04 months. Key findings include:
- Regional Phenotypes: 91.7% of the cohort had MPA, and 81.25% were female, differing from Western demographic trends.
- Baseline eGFR: Patients starting with an eGFR <60 ml/min/1.73 m² were significantly more likely to fail induction therapy and progress to ESRD (p = 0.013).
- Hypertension: The presence of hypertension at diagnosis was a strong independent predictor of ESRD progression (p = 0.001).
Conclusion and Future Directions
This study identifies initial renal failure, hypertension, sclerotic pathological subtype, and lack of response to induction treatment as primary predictors of poor long-term renal outcomes in pediatric AAV. While limited by a small, single-center sample size, these findings provide vital data for managing AAV in East Asian pediatric populations. Future multi-center prospective studies are necessary to refine these risk models and evaluate newer therapeutic agents like Rituximab in this specific demographic.
Summary updated